Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Apr 24, 2019 4:55pm
100 Views
Post# 29666329

RE:Increased promotion

RE:Increased promotion
Wow that sounds very exciting, 2019 surely is Ceapro's year!!!
 

Although it seems kind of familiar.  From a 2017 investor presentation:
 
"Pivoting into Biopharmaceutical company with multiple near-term value-driving opportunities expected to unlock significant shareholder value"

And much better than the usual vague platitudes they've been giving for years:
 
"2016 established a strong foundation for a transformational 2017"
 

digitel wrote: As CZO's April presentation says,  "multiple near-term value-driving opportunities expected to unlock significant shareholder value" the company is increasing its promotional activity as with the Proactive Investors interview and now the ThinkEquity conference.

A good sign that we are out of the tedious work involving getting the plant running, etc., and into the more exciting period for the company.




Bullboard Posts